Literature DB >> 10871019

Effects of contrast material on single-volume proton MR spectroscopy.

J K Smith1, L Kwock, M Castillo.   

Abstract

BACKGROUND AND
PURPOSE: Administration of contrast material before proton MR spectroscopy may allow more accurate placement of the volume of interest, particularly in tumors; yet, some data have suggested that contrast material may alter the results of MR spectroscopy. To determine the validity of this contention, we performed pre- and postcontrast MR spectroscopy in patients with brain tumors and compared the results with those obtained from a phantom.
METHODS: Ten patients with astrocytomas were examined with single-volume MR spectroscopy before and after administration of contrast material. Voxel placement was identical for all studies. Peak area, peak height, and width at half maximum were measured for N-acetyl aspartate (NAA), creatine (Cr), and choline (Cho) in all studies. A phantom containing a 10 mmol concentration of NAA, Cr, and Cho was prepared in phosphate-buffered saline and mixed with contrast concentrations varying from 0.1 to 1.0 mmol. The phantom was studied by MR spectroscopy with the same parameters as used for the clinical studies.
RESULTS: No significant differences were found between the pre- and postcontrast MR spectroscopy studies for the three parameters measured. In phantom studies, there was a significant decline in the Cho peak area and height and an increase in the width at half maximum as the concentration of contrast material increased from 0.1 to 1.0 mmol. NAA and Cr peaks showed no significant changes in peak height or area.
CONCLUSION: Contrast material may be administered before clinical MR spectroscopy without affecting its interpretation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10871019      PMCID: PMC7973894     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  5 in total

1.  Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy.

Authors:  C T Moonen; M von Kienlin; P C van Zijl; J Cohen; J Gillen; P Daly; G Wolf
Journal:  NMR Biomed       Date:  1989-12       Impact factor: 4.044

2.  1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast.

Authors:  P E Sijens; M J van den Bent; P J Nowak; P van Dijk; M Oudkerk
Journal:  Magn Reson Med       Date:  1997-02       Impact factor: 4.668

3.  1H MR spectroscopy monitoring of changes in choline peak area and line shape after Gd-contrast administration.

Authors:  P E Sijens; M Oudkerk; P van Dijk; P C Levendag; C J Vecht
Journal:  Magn Reson Imaging       Date:  1998-12       Impact factor: 2.546

4.  Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro.

Authors:  J P Usenius; P Vainio; J Hernesniemi; R A Kauppinen
Journal:  J Neurochem       Date:  1994-10       Impact factor: 5.372

5.  In vivo 1H MRS choline: correlation with in vitro chemistry/histology.

Authors:  B L Miller; L Chang; R Booth; T Ernst; M Cornford; D Nikas; D McBride; D J Jenden
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

  5 in total
  16 in total

1.  MR Spectroscopy in the diagnosis and treatment of breast cancer.

Authors:  Michael T Nelson; Lenore I Everson; Michael Garwood; Tim Emory; Patrick J Bolan
Journal:  Semin Breast Dis       Date:  2008-06-01

Review 2.  Metabolite quantification and high-field MRS in breast cancer.

Authors:  Ihab S Haddadin; Adeka McIntosh; Sina Meisamy; Curt Corum; Angela L Styczynski Snyder; Nathaniel J Powell; Michael T Nelson; Douglas Yee; Michael Garwood; Patrick J Bolan
Journal:  NMR Biomed       Date:  2009-01       Impact factor: 4.044

3.  Comments on "In vivo post-contrast 1H-MRS evaluation of malignant and benign breast lesions: a meta-analysis".

Authors:  Zhenyin Liu; Jing Zhang
Journal:  Tumour Biol       Date:  2015-05-22

4.  In vivo post-contrast 1H-MRS evaluation of malignant and benign breast lesions: a meta-analysis.

Authors:  Jieying Tan; Li Xu; Wenqing Yao; Yun Wan; Shuqin Zhou; Sherman Xuegang Xin
Journal:  Tumour Biol       Date:  2014-09-27

5.  Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile.

Authors:  Mikhail F Chernov; Motohiro Hayashi; Masahiro Izawa; Yuko Ono; Tomokatsu Hori
Journal:  Int J Clin Oncol       Date:  2006-10       Impact factor: 3.402

6.  Noninvasive detection of temozolomide in brain tumor xenografts by magnetic resonance spectroscopy.

Authors:  Yoshinori Kato; David A Holm; Baasil Okollie; Dmitri Artemov
Journal:  Neuro Oncol       Date:  2009-10-20       Impact factor: 12.300

7.  The effect of paramagnetic contrast in choline peak in patients with glioblastoma multiforme might not be significant.

Authors:  E C Lima; M C G Otaduy; M Tsunemi; R Pincerato; E F Cardoso; S Rosemberg; P H Aguiar; G G Cerri; C C Leite
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-05       Impact factor: 3.825

8.  Proton MR spectroscopy of tumefactive demyelinating lesions.

Authors:  Amit M Saindane; Soonmee Cha; Meng Law; Xiaonan Xue; Edmond A Knopp; David Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

9.  Evaluation of Breast Lipid Composition in Patients with Benign Tissue and Cancer by Using Multiple Gradient-Echo MR Imaging.

Authors:  Melanie Freed; Pippa Storey; Alana Amarosa Lewin; James Babb; Melanie Moccaldi; Linda Moy; Sungheon G Kim
Journal:  Radiology       Date:  2016-06-07       Impact factor: 11.105

10.  Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.

Authors:  Meng Law; Stanley Yang; Hao Wang; James S Babb; Glyn Johnson; Soonmee Cha; Edmond A Knopp; David Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.